{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:07:45Z","timestamp":1778692065393,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jocn.2022.08.017","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T12:21:28Z","timestamp":1662121288000},"page":"31-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Role of lymphocyte-related immune-inflammatory biomarkers in detecting early progression of Guillain-Barr\u00e9 syndrome"],"prefix":"10.1016","volume":"105","author":[{"given":"Lu","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian-Xiao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Hui","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Min","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin-Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jocn.2022.08.017_b0005","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41582-019-0250-9","article-title":"Diagnosis and management of Guillain-Barr\u00e9 syndrome in ten steps","volume":"15","author":"Leonhard","year":"2019","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"10.1016\/j.jocn.2022.08.017_b0010","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.vaccine.2010.06.003","article-title":"Guillain-Barr\u00e9 syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data","volume":"29","author":"Sejvar","year":"2011","journal-title":"Vaccine"},{"issue":"10280","key":"10.1016\/j.jocn.2022.08.017_b0015","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0140-6736(21)00517-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"397","author":"Shahrizaila","year":"2021","journal-title":"Lancet (London, England)"},{"issue":"1","key":"10.1016\/j.jocn.2022.08.017_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1684\/ecn.2019.0424","article-title":"Autoimmunity and cytokines in Guillain-Barr\u00e9 syndrome revisited: review of pathomechanisms with an eye on therapeutic options","volume":"30","author":"Ebrahim Soltani","year":"2019","journal-title":"Eur Cytokine Netw"},{"issue":"4","key":"10.1016\/j.jocn.2022.08.017_b0025","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1212\/WNL.51.4.1110","article-title":"The spectrum of antecedent infections in Guillain-Barr\u00e9 syndrome: a case-control study","volume":"51","author":"Jacobs","year":"1998","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jocn.2022.08.017_b0030","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3109\/14397595.2015.1091136","article-title":"Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients","volume":"26","author":"Qin","year":"2016","journal-title":"Mod Rheumatol"},{"issue":"18","key":"10.1016\/j.jocn.2022.08.017_b0035","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.clinbiochem.2014.08.022","article-title":"Red blood cell distribution width and neutrophil\/lymphocyte ratio are positively correlated with disease activity in primary Sj\u00f6gren\u2019s syndrome","volume":"47","author":"Hu","year":"2014","journal-title":"Clin Biochem"},{"issue":"12","key":"10.1016\/j.jocn.2022.08.017_b0040","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1111\/1756-185X.13404","article-title":"Neutrophil-to-lymphocyte ratio, mean platelet volume and platelet-to-lymphocyte ratio in Beh\u00e7et's disease and their correlation with disease activity: a meta-analysis","volume":"21","author":"Lee","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.jocn.2022.08.017_b0045","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.709553","article-title":"Systemic inflammation index values are associated with worsened disease severity and poor response to autoimmune encephalitis treatment","volume":"12","author":"Mei","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.jocn.2022.08.017_b0050","doi-asserted-by":"crossref","first-page":"102604","DOI":"10.1016\/j.msard.2020.102604","article-title":"The clinical features and prognosis of anti-NMDAR encephalitis depends on blood brain barrier integrity","volume":"47","author":"Yu","year":"2021","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"10.1016\/j.jocn.2022.08.017_b0055","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-021-02432-0","article-title":"Association of neutrophil-to-lymphocyte ratio (NLR) with the prognosis of first attack neuromyelitis optica spectrum disorder (NMOSD): a retrospective cohort study","volume":"21","author":"Xie","year":"2021","journal-title":"BMC neurol"},{"key":"10.1016\/j.jocn.2022.08.017_b0060","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.628024","article-title":"An abnormally high neutrophil-to-lymphocyte ratio is not an independent outcome predictor in AQP4-IgG-positive NMOSD","volume":"12","author":"Carnero Contentti","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.jocn.2022.08.017_b0065","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12883-019-1245-2","article-title":"The neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios are independently associated with neurological disability and brain atrophy in multiple sclerosis","volume":"19","author":"Hemond","year":"2019","journal-title":"BMC Neurol"},{"issue":"8","key":"10.1016\/j.jocn.2022.08.017_b0070","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1080\/00207454.2017.1418342","article-title":"The clinical significance of neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio in Guillain-Barr\u00e9 syndrome","volume":"128","author":"Huang","year":"2018","journal-title":"Int J Neurosci"},{"issue":"9","key":"10.1016\/j.jocn.2022.08.017_b0075","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1590\/0004-282X20160132","article-title":"Analysis of the albumin level, neutrophil-lymphocyte ratio, and platelet-lymphocyte ratio in Guillain-Barr\u00e9 syndrome","volume":"74","author":"Ozdemir","year":"2016","journal-title":"Arq Neuropsiquiatr"},{"issue":"3","key":"10.1016\/j.jocn.2022.08.017_b0080","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/brain\/118.3.597","article-title":"Guillain-Barr\u00e9 syndrome in northern China Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies","volume":"118","author":"Ho","year":"1995","journal-title":"Brain"},{"issue":"8093","key":"10.1016\/j.jocn.2022.08.017_b0085","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","article-title":"Controlled trial prednisolone in acute polyneuropathy","volume":"2","author":"Hughes","year":"1978","journal-title":"Lancet (London, England)"},{"issue":"7","key":"10.1016\/j.jocn.2022.08.017_b0090","doi-asserted-by":"crossref","first-page":"e0133520","DOI":"10.1371\/journal.pone.0133520","article-title":"Subtypes and prognosis of guillain-barr\u00e9 syndrome in southwest China","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.jocn.2022.08.017_b0095","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00281-013-0374-8","article-title":"Neutrophils in innate and adaptive immunity","volume":"35","author":"Jaillon","year":"2013","journal-title":"Semin Immunopathol"},{"issue":"3","key":"10.1016\/j.jocn.2022.08.017_b0100","doi-asserted-by":"crossref","first-page":"e90463","DOI":"10.1371\/journal.pone.0090463","article-title":"CCR2 gene deletion and pharmacologic blockade ameliorate a severe murine experimental autoimmune neuritis model of Guillain-Barr\u00e9 syndrome","volume":"9","author":"Yuan","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jocn.2022.08.017_b0105","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3389\/fimmu.2017.00336","article-title":"Adaptive immunity is the key to the understanding of autoimmune and paraneoplastic inflammatory central nervous system disorders","volume":"8","author":"Weissert","year":"2017","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.jocn.2022.08.017_b0110","doi-asserted-by":"crossref","first-page":"500","DOI":"10.5603\/CJ.a2013.0148","article-title":"Neutrophil to lymphocyte ratio predicts short- and long-term mortality following revascularization therapy for ST elevation myocardial infarction","volume":"21","author":"Sawant","year":"2014","journal-title":"Cardiol J"},{"issue":"6","key":"10.1016\/j.jocn.2022.08.017_b0115","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00005-012-0193-y","article-title":"Platelets in inflammation and immune modulations: functions beyond hemostasis","volume":"60","author":"Huang","year":"2012","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"5","key":"10.1016\/j.jocn.2022.08.017_b0120","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1189\/jlb.0907615","article-title":"Platelet-lymphocyte cross-talk","volume":"83","author":"Li","year":"2008","journal-title":"J Leukoc Biol"},{"issue":"13","key":"10.1016\/j.jocn.2022.08.017_b0125","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1016\/j.cell.2022.05.020","article-title":"Bone marrow hematopoiesis drives multiple sclerosis progression","volume":"185","author":"Shi","year":"2022","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.jocn.2022.08.017_b0130","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jhep.2012.06.022","article-title":"A novel and validated prognostic index in hepatocellular carcinoma: the inflammation based index (IBI)","volume":"57","author":"Pinato","year":"2012","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.jocn.2022.08.017_b0135","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1212\/WNL.0b013e3181e7920c","article-title":"Axonal variant of Guillain-Barre syndrome associated with campylobacter infection in Bangladesh","volume":"75","author":"Zhang","year":"2010","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jocn.2022.08.017_b0140","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/mus.24908","article-title":"Locked-in-like fulminant infantile Guillain-Barr\u00e9 syndrome associated with herpes simplex virus 1 infection","volume":"53","author":"Dilena","year":"2016","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.jocn.2022.08.017_b0145","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","article-title":"Guillain-Barre syndrome following vaccination in the national influenza immunization program, United States, 1976\u20131977","volume":"110","author":"Schonberger","year":"1979","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.jocn.2022.08.017_b0150","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/ana.26144","article-title":"Guillain-barr\u00e9 syndrome variant occurring after SARS-CoV-2 vaccination","volume":"90","author":"Allen","year":"2021","journal-title":"Ann Neurol"},{"issue":"10","key":"10.1016\/j.jocn.2022.08.017_b0155","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1001\/jamaneurol.2017.1912","article-title":"Neurological complications associated with anti-programmed death 1 (PD-1) Antibodies","volume":"74","author":"Kao","year":"2017","journal-title":"JAMA Neurol"},{"issue":"3","key":"10.1016\/j.jocn.2022.08.017_b0160","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00005792-196905000-00001","article-title":"The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis","volume":"48","author":"Asbury","year":"1969","journal-title":"Medicine"},{"issue":"Pt 9","key":"10.1016\/j.jocn.2022.08.017_b0165","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1093\/brain\/awg207","article-title":"Distinct time pattern of complement activation and cytotoxic T cell response in Guillain-Barr\u00e9 syndrome","volume":"126","author":"Wanschitz","year":"2003","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.jocn.2022.08.017_b0170","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.expneurol.2011.11.039","article-title":"Dysfunction of nodes of Ranvier: a mechanism for anti-ganglioside antibody-mediated neuropathies","volume":"233","author":"Susuki","year":"2012","journal-title":"Exp Neurol"},{"issue":"1","key":"10.1016\/j.jocn.2022.08.017_b0175","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF02284784","article-title":"Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barr\u00e9 syndrome","volume":"25","author":"Griffin","year":"1996","journal-title":"J Neurocytol"},{"issue":"4","key":"10.1016\/j.jocn.2022.08.017_b0180","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ana.410400414","article-title":"Acute motor axonal neuropathy: an antibody-mediated attack on axolemma","volume":"40","author":"Hafer-Macko","year":"1996","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.jocn.2022.08.017_b0185","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/ana.410330402","article-title":"Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China","volume":"33","author":"McKhann","year":"1993","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.jocn.2022.08.017_b0190","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.cytogfr.2013.05.005","article-title":"Th1\/Th2\/Th17\/Treg cytokines in Guillain-Barr\u00e9 syndrome and experimental autoimmune neuritis","volume":"24","author":"Zhang","year":"2013","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jocn.2022.08.017_b0195","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cca.2015.02.039","article-title":"Autoimmune peripheral neuropathies","volume":"449","author":"Bourque","year":"2015","journal-title":"Clin Chim Acta"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586822003435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586822003435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:30:36Z","timestamp":1760823036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586822003435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":39,"alternative-id":["S0967586822003435"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2022.08.017","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of lymphocyte-related immune-inflammatory biomarkers in detecting early progression of Guillain-Barr\u00e9 syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2022.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}